Loading stock data...

TAKE Solutions Limited

NSE: TAKE BSE: TAKE

NSE
45.64 -1.06 (-2.27%)

Prev Close

46.7

Open Price

47

Volume

1,109,518

Today Low / High

44.37 / 47.12

52 WK Low / High

6.51 / 49.94

Range

43 - 48

BSE
45.11 -1.82 (-3.88%)

Prev Close

46.93

Open Price

46.99

Volume

108,377

Today Low / High

44.59 / 47.45

52 WK Low / High

6.7 / 49.9

Range

43 - 47

The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 45.64 (target range: 43 - 48), reflecting a change of -1.06 (-2.26981%). On the BSE, it is listed at 45.11 (target range: 43 - 47), showing a change of -1.82 (-3.87812%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.

25 Feb 47.00 -2.89%
24 Feb 46.90 -0.43%
23 Feb 47.69 -2.01%
20 Feb 47.35 -0.27%
19 Feb 48.00 -1.52%
18 Feb 47.80 -1.13%
17 Feb 45.55 4.26%
16 Feb 49.00 -4.73%
13 Feb 49.00 -0.31%
12 Feb 47.30 2.62%
11 Feb 46.95 0.40%
10 Feb 44.95 4.14%
09 Feb 43.50 3.06%
06 Feb 42.59 1.60%
05 Feb 42.05 -0.95%
04 Feb 42.54 -1.15%
03 Feb 42.90 -0.84%
02 Feb 42.75 -0.16%
01 Feb 42.00 1.62%
30 Jan 40.50 2.57%
29 Jan 38.50 4.83%
28 Jan 37.00 3.92%

TAKE Solutions Limited Graph

TAKE Solutions Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges

If you are looking for the target price for TAKE Solutions Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 45.64, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.

Scenario Price Target Range
Bullish Scenario 45.11 45.56 41.00 - 50.12
46.01 36.81 - 55.21
46.46 32.52 - 60.40
Bearish Scenario 45.11 44.66 40.19 - 49.12
44.21 35.37 - 53.05
43.76 30.63 - 56.88

Overview of TAKE Solutions Limited

ISIN

INE142I01023

Industry

Biotechnology

Vol.Avg

1,630,719

Market Cap

6,751,707,760

Last Dividend

0

Official Website

Visit Website

IPO Date

2007-08-27

DCF Diff

45.36

DCF

0

Financial Ratios Every Investor Needs

Stock Dividend of TAKE

Date Label Adj Dividend Dividend Record Date Payment Date Declaration Date
2019-08-01 August 01, 19 0.4 0.4 2019-08-02 2019-09-06 2019-05-16
2019-02-22 February 22, 19 0.3 0.3 2019-02-25 2019-03-15 2019-02-13
2018-11-09 November 09, 18 0.3 0.3 2018-11-12 2018-11-29 2018-10-30
2018-08-02 August 02, 18 0.6 0.6 2018-08-03 2018-09-07 2018-05-17
2018-02-15 February 15, 18 0.3 0.3 2018-02-19 2018-03-09 2018-02-06

Stock Rating Details for TAKE

Metric Value Recommendation
Overall Rating D+ Strong Sell
DCF Score 2 Sell
ROE Score 1 Strong Sell
ROA Score 1 Strong Sell
Debt-to-Equity (DE) Score 1 Strong Sell
Price-to-Earnings (PE) Score 1 Strong Sell
Price-to-Book (PB) Score 1 Strong Sell

Annual Financial Income Report

Date Revenue Co.Rev GP GPR R&D Expenses G&A Expenses Operating Income Net Income EPS EBITDA NIR
2025-03-31 0.00 Cr 0.05 Cr -0.05 Cr 0.0000 0.00 Cr 0.03 Cr -7.52 Cr 37.47 Cr 2.56 2.74 Cr 0.0000
2024-03-31 65.61 Cr 24.44 Cr 41.17 Cr 0.6275 0.01 Cr 7.87 Cr -5.61 Cr -119.62 Cr -8.18 -105.08 Cr -1.8233
2023-03-31 189.07 Cr 83.01 Cr 106.06 Cr 0.5610 0.01 Cr 9.98 Cr 5.82 Cr -100.27 Cr -6.86 -20.98 Cr -0.5303
2022-03-31 652.65 Cr 192.85 Cr 459.79 Cr 0.7045 7.07 Cr 76.93 Cr -60.11 Cr -782.25 Cr -53.50 26.90 Cr -1.1986
2021-03-31 774.02 Cr 188.08 Cr 585.94 Cr 0.7570 13.06 Cr 69.84 Cr -149.89 Cr -452.02 Cr -30.91 -286.13 Cr -0.5840

Annual Financials Balance Sheet

Date C&C Equ. Tot. Assets Tot. Liab. Stock. Equity Tot. Debt Net Debt Inv. PP&E (Net) Curr. Def. Rev. Non-Curr. Def. Rev. LT Invest. Curr. Liab.
2025-03-31 3.37 Cr 36.48 Cr 15.95 Cr 20.5270 Cr 0.00 Cr -3.37 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 15.9540 Cr
2024-03-31 0.85 Cr 88.11 Cr 96.98 Cr -8.8730 Cr 37.09 Cr 36.24 Cr 0.80 Cr 28.50 Cr 18.61 Cr 0.00 Cr 3.13 Cr 89.1570 Cr
2023-03-31 10.72 Cr 224.38 Cr 115.78 Cr 108.6020 Cr 46.37 Cr 35.65 Cr 0.78 Cr 54.15 Cr 0.00 Cr 0.00 Cr 0.00 Cr 100.9010 Cr
2022-03-31 29.00 Cr 1,223.10 Cr 1,042.47 Cr 181.0430 Cr 77.99 Cr 48.99 Cr 0.65 Cr 48.17 Cr 33.46 Cr 0.00 Cr -5.96 Cr 1,006.7520 Cr
2021-03-31 32.42 Cr 1,844.59 Cr 720.29 Cr 1,124.6920 Cr 549.67 Cr 517.25 Cr 0.61 Cr 229.98 Cr 49.20 Cr 0.00 Cr 7.37 Cr 524.2980 Cr

Annual Financials Cash Flow Statement

Date Operating Cash Investing Cash Financing Cash Free Cash Cash Change Cash at End CapEx Income Debt Repay Dividends Inventory
2025-03-31 -16.3660 Cr 22.0200 Cr -3.2390 Cr -16.3660 Cr 2.5220 Cr 3.3670 Cr 0.0000 Cr 37.4400 Cr -3.2000 Cr -0.0390 Cr 0.0000 Cr
2024-03-31 9.3160 Cr -7.4620 Cr -11.7350 Cr 1.4000 Cr -9.8780 Cr 0.8450 Cr -7.9160 Cr -119.6200 Cr -5.3000 Cr -0.0730 Cr -0.0200 Cr
2023-03-31 20.0150 Cr -2.1252 Cr -35.7210 Cr -12.3810 Cr -18.2740 Cr 10.7236 Cr -32.3960 Cr -98.6740 Cr -25.2520 Cr -0.0680 Cr -0.1270 Cr
2022-03-31 120.3110 Cr -30.6410 Cr -54.5170 Cr 89.0990 Cr -9.9770 Cr 28.9970 Cr -31.2120 Cr -771.0180 Cr -8.0880 Cr -0.0070 Cr 0.0000 Cr
2021-03-31 135.2390 Cr -56.9890 Cr -83.9460 Cr 132.0840 Cr -6.1580 Cr 38.9740 Cr -3.1480 Cr -435.6200 Cr -40.6790 Cr 0.0000 Cr 0.0000 Cr

Quarterly Financial Income Report

Date Revenue Co.Rev GP GPR Operating Income Net Income EPS EBITDA NIR
2025-12-31 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -0.35 Cr 1.11 Cr 0.08 -0.35 Cr 0.0000
2025-09-30 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -0.30 Cr 6.29 Cr 0.43 -0.47 Cr 0.0000
2025-06-30 0.00 Cr 0.00 Cr 0.00 Cr 0.0000 -0.78 Cr -0.91 Cr -0.06 -0.73 Cr 0.0000
2025-03-31 0.00 Cr 0.01 Cr -0.01 Cr 0.0000 -1.15 Cr -4.88 Cr -0.33 0.56 Cr 0.0000
2024-12-31 8.52 Cr 0.00 Cr -0.01 Cr -0.0013 -1.89 Cr 47.68 Cr 3.26 5.63 Cr 5.5939

Quarterly Financials Balance Sheet

Date Cash & Equiv. Short-Term Inv. Cash & Short-Term Net Receivables Inventory Total Curr. Assets PP&E (Net) Total Assets Total Liabilities
2025-09-30 0.15 Cr 0.00 Cr 0.15 Cr 0.00 Cr 0.00 Cr 22.29 Cr 0.00 Cr 35.21 Cr 9.58 Cr
2025-06-30 0.00 Cr 0.00 Cr 3.43 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr -20.53 Cr
2025-03-31 3.37 Cr 0.00 Cr 15.69 Cr 58.75 Cr 0.00 Cr 23.55 Cr 0.00 Cr 36.48 Cr 15.95 Cr
2024-12-31 0.00 Cr 0.00 Cr 0.61 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 14.17 Cr
2024-09-30 0.51 Cr 0.68 Cr 1.19 Cr 0.29 Cr 0.00 Cr 72.55 Cr 0.07 Cr 86.70 Cr 100.87 Cr

Quarterly Financials Cash Flow Statement

Date Net Income Operating Cash Flow Investing Cash Flow Financing Cash Flow Net Cash Change Cash at End Cash at Beginning CapEx Free Cash Flow
2025-06-30 -0.91 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2025-03-31 -4.88 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-12-31 47.68 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-09-30 -1.58 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr
2024-06-30 -3.75 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr 0.00 Cr

Splits History

Date Label Split Ratio
2008-09-18 September 18, 08 10:1

Similar Stocks: Biotechnology

Company Name Symbol Price Market Cap Volume
Biocon Limited BIOCON ₹395.85 ₹502,400,431,478.00 ₹3,958,795.00
Anthem Biosciences Ltd. ANTHEM ₹704.10 ₹395,502,722,489.00 ₹355,793.00
Piramal Pharma Limited PPLPHARMA ₹161.06 ₹213,141,551,189.00 ₹1,291,793.00
Syngene International Limited SYNGENE ₹433.60 ₹174,199,573,542.00 ₹1,063,178.00
Onesource Specialty Pharma Ltd. ONESOURCE ₹1,292.80 ₹148,182,287,360.00 ₹112,142.00
Concord Biotech Limited CONCORDBIO ₹1,230.90 ₹128,772,085,504.00 ₹11,424,002.00
Jubilant Ingrevia Limited JUBLINGREA ₹593.30 ₹93,747,858,071.00 ₹117,147.00
Blue Jet Healthcare Limited BLUEJET ₹399.75 ₹69,342,803,644.00 ₹1,270,572.00
Supriya Lifescience Limited SUPRIYA ₹665.20 ₹53,537,158,560.00 ₹65,822.00
Zota Health Care Limited ZOTA ₹1,214.80 ₹36,848,109,294.00 ₹83,147.00
Dishman Carbogen Amcis Limited DCAL ₹175.53 ₹27,520,136,665.00 ₹195,704.00

Key Executives

Non-Executive Director
Srinivasan Ramani Harikesavanallur

Gender: male

Year Born: 1964

Chief Financial Officer & Whole Time Director
Vedamirtham Venkatesan

Gender: male

Year Born: 1965

Company Secretary & Compliance Officer
Sonia Bhimrajka

Gender: female

Year Born:

FAQs about TAKE Solutions Limited

Who is the CEO of the company?

The CEO is Vandana Gupta.

What is the current market price of the stock?

The current price is ₹45.64.

What is the 52-week price range?

The range is ₹6.51-49.94.

What is the market capitalization of the company?

The market capitalization is ₹675.17 crores.

What is the Price-to-Earnings (P/E) ratio?

The P/E ratio is 414.75.

Which sector does the company belong to?

The company operates in the Healthcare sector.

What does the company do?

Overview of TAKE Solutions Limited (ISIN: INE142I01023) is a leading Biotechnology in India. With a market capitalization of ₹675.17 crores and an average daily volume of 1,630,719 shares, it operates in the Biotechnology. The company last declared a dividend of ₹0.